Astex Announces Exclusive Research Collaboration and License Agreement with Genentech for Breast Cancer Therapy Program
Collaboration leverages Astex’s industry-leading, fragment-based drug discovery capability to
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.